Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025GenesOpen Access

A Genetically-Informed Network Model of Myelodysplastic Syndrome: From Splicing Aberrations to Therapeutic Vulnerabilities

View Full Paper
Ask AI
Bookmark
Share

Authors

SYSanghyeon YuKyung Hee UniversityJKJunghyun KimNational Cancer CenterMKMan S. Kim

Discussion

Loading...

Member takes

Implication

Review synthesizes mechanisms behind myelodysplastic syndrome, revealing splicing and epitranscriptomic factors influencing treatment outcomes.

Key Points

  • Myelodysplastic syndrome patients show varied responses to therapies, with some responding well while others fail treatment.
  • Four mechanisms drive MDS pathology: genetic alterations, aberrant stem cell architecture, dysregulated epitranscriptomics, and microenvironment changes.
  • Analyzing single-cell technologies reveals important insights about splicing aberrations and their impact on treatment response.
  • Understanding these mechanisms can help transition toward precision medicine, improving therapeutic strategies for MDS patients.

Cite This Study

Yu et al. (2025) studied this question.

synapsesocial.com/papers/68c241efb210217d647a1fd5https://doi.org/10.3390/genes16080928
View Full Paper
Ask AI
Bookmark
Share